However, no significant differences were observed in the serum levels of VCA-IgG (χ2 = 0.669; P = 0.413) or VCA-IgM (χ2 = 0.953; P = 0.329) between the NPC and control groups (Table 1). The gene discussed is CD40LG; the disease is nasopharyngeal carcinoma.